Literature DB >> 29455264

Mortality Rate and Predictors in Children Under 15 Years Old Who Acquired HIV from Mother to Child Transmission in Paraguay.

Gloria Aguilar1,2,3, Angélica Espinosa Miranda4, George W Rutherford5, Sergio Munoz6, Nancy Hills7, Tania Samudio8, Fernando Galeano9, Anibal Kawabata10, Carlos Miguel Rios González10.   

Abstract

We estimated mortality rate and predictors of death in children and adolescents who acquired HIV through mother-to-child transmission in Paraguay. In 2000-2014, we conducted a cohort study among children and adolescents aged < 15 years. We abstracted data from medical records and death certificates. We used the Cox proportional hazards model for the multivariable analysis of mortality predictors. A total of 302 subjects were included in the survey; 216 (71.5%) were younger than 5 years, 148 (51.0%) were male, and 214 (70.9%) resided in the Asunción metropolitan area. There were 52 (17.2%) deaths, resulting in an overall mortality rate of 2.06 deaths per 100 person-years. The children and adolescents with hemoglobin levels ≤ 9 g/dL at baseline had a 2-times higher hazard of death compared with those who had levels > 9 g/dL (HR 2.27, 95% CI 1.01-5.10). The mortality of HIV-infected children and adolescents in Paraguay is high, and anemia is associated with mortality. Improving prenatal screening to find cases earlier and improving pediatric follow-up are needed.

Entities:  

Keywords:  Child; HIV; Mortality; Paraguay

Mesh:

Year:  2018        PMID: 29455264      PMCID: PMC6126538          DOI: 10.1007/s10461-018-2053-1

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  11 in total

1.  Guidelines for the use of antiretroviral agents in pediatric HIV infection, January 7, 2000.

Authors: 
Journal:  HIV Clin Trials       Date:  2000 Nov-Dec

2.  The impact of highly active antiretroviral therapy on the survival of vertically HIV-infected children and adolescents in Belo Horizonte, Brazil.

Authors:  Claudete Aparecida Araújo Cardoso; Jorge A Pinto; Talitah Michel Sanchez Candiani; Inácio Roberto de Carvalho; Renato Moreira Linhares; Eugênio Marcos Andrade Goulart
Journal:  Mem Inst Oswaldo Cruz       Date:  2012-06       Impact factor: 2.743

3.  Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children.

Authors:  P E Palumbo; C Raskino; S Fiscus; S Pahwa; M G Fowler; S A Spector; J A Englund; C J Baker
Journal:  JAMA       Date:  1998-03-11       Impact factor: 56.272

4.  The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.

Authors:  L M Mofenson; J Korelitz; W A Meyer; J Bethel; K Rich; S Pahwa; J Moye; R Nugent; J Read
Journal:  J Infect Dis       Date:  1997-05       Impact factor: 5.226

5.  Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.

Authors:  E J Abrams; J Weedon; R W Steketee; G Lambert; M Bamji; T Brown; M L Kalish; E E Schoenbaum; P A Thomas; D M Thea
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

6.  [Highly active antiretroviral therapy in HIV sero-positive children. Disease progression by baseline clinical, immunological and virological status].

Authors:  M Susana Rodríguez de Schiavi; Adriana Scrigni; Patricia García Arrigoni; Rosa Bologna; Graciela Barboni; Julia Redondo; Mariana Nastri; Débora Mecikovsky; Claudio Cantisano; Rina Moreno; Darío Siciliani; Mónica Lencina; Nora Luedicke; Gabriela Rezzónico; José L Torolla; Santiago López Papucci; Miguel Luis; Carmen Libonati; Luis Gamba; Jeanette Barbarysky; Ema Pérez Hernández; Rafael Zlatkes
Journal:  Arch Argent Pediatr       Date:  2009-06       Impact factor: 0.635

7.  Early antiretroviral therapy and mortality among HIV-infected infants.

Authors:  Avy Violari; Mark F Cotton; Diana M Gibb; Abdel G Babiker; Jan Steyn; Shabir A Madhi; Patrick Jean-Philippe; James A McIntyre
Journal:  N Engl J Med       Date:  2008-11-20       Impact factor: 91.245

8.  Early loss to follow-up and mortality of HIV-infected patients diagnosed after the era of antiretroviral treatment scale up: a call for re-invigorating the response in Iran.

Authors:  Banafsheh Moradmand Badie; Ghaemeh Nabaei; Mehrnaz Rasoolinejad; Ali Mirzazadeh; Willi McFarland
Journal:  Int J STD AIDS       Date:  2013-08-06       Impact factor: 1.359

9.  Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial.

Authors:  Mark F Cotton; Avy Violari; Kennedy Otwombe; Ravindre Panchia; Els Dobbels; Helena Rabie; Deirdre Josipovic; Afaaf Liberty; Erica Lazarus; Steve Innes; Anita Janse van Rensburg; Wilma Pelser; Handre Truter; Shabir A Madhi; Edward Handelsman; Patrick Jean-Philippe; James A McIntyre; Diana M Gibb; Abdel G Babiker
Journal:  Lancet       Date:  2013-11-09       Impact factor: 79.321

10.  Mortality in children and adolescents vertically infected by HIV receiving care at a referral hospital in Vitoria, Brazil.

Authors:  Sandra Fagundes Moreira-Silva; Eliana Zandonade; Angélica Espinosa Miranda
Journal:  BMC Infect Dis       Date:  2015-03-25       Impact factor: 3.090

View more
  1 in total

1.  AIDS Prevention Research: Training and Mentoring the Next Generation of Investigators from Low- and Middle-Income Countries.

Authors:  Deborah B Brickley; Christina P Lindan
Journal:  AIDS Behav       Date:  2018-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.